Relative Strength Chart Virax Biolabs Group Limited

Equities

Market Closed - Nasdaq Other stock markets 21:30:00 06/03/2026 GMT			5-day change	1st Jan Change
0.2145 ^USD	+3.62%		-5.80%	-37.97%

12-02	Virax Biolabs Group Limited announced that it expects to receive $5 million in funding	CI
12-02	Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI

End-of-day quotes

		Sector	Change	5d. change	Varia. Jan 1.	1-year change	5-years change	Capi.	ST	MT	LT
	VIRAX BIOLABS GROUP LIMITED	Other Biotechnology & Medical Research	+3.62%	-5.80%	-37.97%	-84.23%	-	1.59M